Shanghai Haohai Biological Tech Co (688366) - Total Liabilities

Latest as of September 2025: CN¥1.23 Billion CNY ≈ $180.52 Million USD

Based on the latest financial reports, Shanghai Haohai Biological Tech Co (688366) has total liabilities worth CN¥1.23 Billion CNY (≈ $180.52 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Shanghai Haohai Biological Tech Co - Total Liabilities Trend (2012–2024)

This chart illustrates how Shanghai Haohai Biological Tech Co's total liabilities have evolved over time, based on quarterly financial data. See working capital position of Shanghai Haohai Biological Tech Co to evaluate short-term liquidity relative to the company's equity base.

Shanghai Haohai Biological Tech Co Competitors by Total Liabilities

The table below lists competitors of Shanghai Haohai Biological Tech Co ranked by their total liabilities.

Company	Country	Total Liabilities
Lexicon Pharmaceuticals Inc NASDAQ:LXRX	USA	$65.96 Million
DNA Link Inc KQ:127120	Korea	₩53.95 Billion
Veken Elite SHG:600152	China	CN¥1.30 Billion
Jastrzebska Spotka Weglowa SA WAR:JSW	Poland	zł9.98 Billion
Rongan Property Co Ltd SHE:000517	China	CN¥6.58 Billion
Beijing WKW Automotive Parts Co Ltd SHE:002662	China	CN¥1.47 Billion
Lg Electronics Pref KO:066575	Korea	₩40.25 Trillion
Wuhan Keqian Biology Co Ltd SHG:688526	China	CN¥580.21 Million

Liability Composition Analysis (2012–2024)

This chart breaks down Shanghai Haohai Biological Tech Co's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 688366 stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	3.77	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.22	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.17	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Shanghai Haohai Biological Tech Co's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Shanghai Haohai Biological Tech Co (2012–2024)

The table below shows the annual total liabilities of Shanghai Haohai Biological Tech Co from 2012 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥1.20 Billion ≈ $176.23 Million	+10.67%
2023-12-31	CN¥1.09 Billion ≈ $159.24 Million	+9.92%
2022-12-31	CN¥990.02 Million ≈ $144.87 Million	+11.23%
2021-12-31	CN¥890.07 Million ≈ $130.25 Million	+57.69%
2020-12-31	CN¥564.46 Million ≈ $82.60 Million	+13.23%
2019-12-31	CN¥498.52 Million ≈ $72.95 Million	-17.04%
2018-12-31	CN¥600.90 Million ≈ $87.93 Million	-15.20%
2017-12-31	CN¥708.59 Million ≈ $103.69 Million	+0.15%
2016-12-31	CN¥707.55 Million ≈ $103.54 Million	+352.18%
2015-12-31	CN¥156.48 Million ≈ $22.90 Million	-0.80%
2014-12-31	CN¥157.74 Million ≈ $23.08 Million	+107.21%
2013-12-31	CN¥76.13 Million ≈ $11.14 Million	+39.17%
2012-12-31	CN¥54.70 Million ≈ $8.00 Million	--

About Shanghai Haohai Biological Tech Co

SHG:688366 China Biotechnology

Market Cap

$839.16 Million

CN¥5.73 Billion CNY

Market Cap Rank

#9852 Global

#2622 in China

Share Price

CN¥30.15

Change (1 day)

-0.17%

52-Week Range

CN¥30.15 - CN¥57.62

All Time High

CN¥268.82